PharmacyCodes



N-Benzoylferrioxamine B en es it fr

N-Benzoylferrioxamine B Brand names, N-Benzoylferrioxamine B Analogs

N-Benzoylferrioxamine B Brand Names Mixture

  • No information avaliable

N-Benzoylferrioxamine B Chemical_Formula

C20H29N3O2

N-Benzoylferrioxamine B RX_link

No information avaliable

N-Benzoylferrioxamine B fda sheet

N-Benzoylferrioxamine B msds (material safety sheet)

N-Benzoylferrioxamine_B MSDS

N-Benzoylferrioxamine B Synthesis Reference

No information avaliable

N-Benzoylferrioxamine B Molecular Weight

343.463 g/mol

N-Benzoylferrioxamine B Melting Point

99-101oC (HCl salt)

N-Benzoylferrioxamine B H2O Solubility

42 mg/L

N-Benzoylferrioxamine B State

Solid

N-Benzoylferrioxamine B LogP

3.588

N-Benzoylferrioxamine B Dosage Forms

Ointment

N-Benzoylferrioxamine B Indication

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.

N-Benzoylferrioxamine B Pharmacology

Dibucaine is an amide-type local anesthetic, similar to lidocaine.

N-Benzoylferrioxamine B Absorption

In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation.

N-Benzoylferrioxamine B side effects and Toxicity

Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.

N-Benzoylferrioxamine B Patient Information

No information avaliable

N-Benzoylferrioxamine B Organisms Affected

Humans and other mammals